Is Hims & Hers Health Stock a Buy?
Hims & Hers Health (NYSE: HIMS) stock has been on a bit of a rollercoaster ride this year. The stock is down about 35% from the highs it hit earlier this year, but is it still up over 85% year to date. As such, investors should probably expect some volatility when investing in the stock.
Let's look at three things investors should consider when contemplating an investment in Hims & Hers and whether the stock is ultimately a buy, sell, or hold at current levels.
Hims & Hers has quietly been one of the strongest growth companies in the healthcare space in the last few years. In 2022, the telemedicine operator grew its revenue by 94%, followed by 65% growth in 2023. That growth continued into 2024, with first-quarter revenue growth of 46% and second-quarter growth of 52%, representing total revenue growth of 49% in the first half.
Source Fool.com
